Medifast, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Medifast (MED) Tops Q4 EPS by 59c, Revenues Beat; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus
February 26, 2020 4:46 PM ESTMedifast (NYSE: MED) reported Q4 EPS of $1.66, $0.59 better than the analyst estimate of $1.07. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $161.69 million.
Fourth Quarter 2019 Highlights Compared to Prior-Year Period
Revenue up 17.0% to $170.6 million32.0% growth in active earning OPTAVIA Coaches to 31,800Net income increased 27.0% to $19.9 millionEarnings per diluted share ("EPS") of $1.66, an increase of 27.7%Declared a quarterly cash dividend of $13.4 million, or $1.13 per share paid on February 6, 2020, an increase of over 50%... More
